Public health guidance on use of interferon-gamma release assays in support of TB diagnosis
This report sets out the evidence on IGRAs and their use in the diagnosis of latent and active tuberculosis.After reviewing all available evidence, the expert panel concluded that ‘IGRAs should not replace the standard diagnostic methods for diagnosing active TB.’
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
Public health guidance on management of contacts of MDR TB and XDR TB patients
The goal of this guidance is to contribute towards preventing as many MDR TB and XDR TB cases as possible in the EU/EEA. Given that MDR TB and XDR TB is becoming more prevalent, the issue of how to manage contacts of MDR TB patients is becoming increasingly relevant. The specific aim of this document is to provide guidance on issues relevant to the management of contacts of MDR TB and XDR TB patients.
A network strategy to advance public health in Europe
Semenza, J.C., Apfel, F., Rose, T., Giesecke, J.
TB Policy Briefing Design - .Zip File
TB Policy Briefing Design File.zip
Tuberculosis (TB) is a serious infectious disease that although treatable, can be fatal. In 2014, it affected around 58 000 people in the European Union/European Economic Area (EU/EEA).
Barriers and facilitators for the uptake of tuberculosis diagnostic and treatment services by hard-to-reach populations in low- and medium-incidence countries: A systematic review of qualitative literature
Tuberculosis (TB) disproportionally affects hard-to-reach populations such as people who are homeless, migrants, refugees, prisoners, or drug users. These people often face challenges in accessing quality healthcare services.
Supplementary Web Appendices for Tuberculosis in hard-to-reach populations 2
Effectiveness of interventions for diagnosis and treatment of tuberculosis in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review - appendices.
Systematic review on the diagnosis, treatment, care and prevention of tuberculosis in prison settings
The objective of this report is to systematically review data on the diagnosis, treatment, care and prevention of tuberculosis in prison settings, with a focus on the countries of the European Union and the European Economic Area.
Public health guidance on active case finding of communicable diseases in prison settings
This joint guidance from ECDC and the European Monitoring Centre for Drugs and Drug Addiction provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.